閉塞性喉頭炎治療の世界市場レポート 2025年

閉塞性喉頭炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.6％で25億7,000万米ドルに成長します。予測期間の成長は、治療オプションに対するニーズの増加、細菌およびウイルス感染症の発生率の増加、高齢化人口の増加、有害化学物質への曝露の増加、ヘルスケア支出の増加に起因しています。予測期間の主な動向には、技術の進歩、遠隔医療、生物学的治療、画像診断、機械学習などの統合が含まれます。

閉塞性喉頭炎治療市場の成長は、細菌およびウイルス感染症の罹患率の上昇によって牽引されると予測されます。細菌やウイルスなどの微生物によって引き起こされるこれらの感染症は、体内に侵入して繁殖し、正常な身体機能を破壊します。これらの感染症の発生率増加の要因としては、世界の旅行の増加、気候変動、抗生物質耐性などが挙げられます。閉塞性喉頭炎の治療には通常、病原体を除去し炎症を抑えるために抗生物質と副腎皮質ステロイドが使用されるが、ウイルス感染症は対症療法、重度の炎症に対する副腎皮質ステロイド、声の安静や水分補給などの支持療法で管理されます。例えば、2023年11月、世界保健機関（WHO）は、2022年の結核患者数は全世界で約1,060万人に達し、580万人の男性、350万人の女性、130万人の子供に影響が及ぶと推定しています。このような細菌およびウイルス感染症の罹患率の上昇が、閉塞性喉頭炎治療市場の成長に拍車をかけています。

閉塞性喉頭炎治療市場の主要企業は、酸が食道に逃げるのを防ぎ、痛みや不快感を和らげるチュアブル錠などの革新的ソリューションの開発に注力しています。チュアブル錠は、飲み込む前に噛むことで、より簡単に摂取でき、より早く吸収されるように設計された固形の薬剤です。例えば、2024年6月、インドの製造会社Akums Drugs and Pharmaceuticals Ltd.は、アルギン酸ナトリウムと炭酸水素カリウムを含むチュアブル逆流防止制酸錠を発売しました。このチュアブル錠は、主に酸逆流や胃食道逆流症（GERD）の治療に使用されます。喉頭炎の治療においては、喉頭炎の一因または悪化の原因となる酸の逆流による喉頭の炎症を抑えます。胃の中で保護バリアを形成することで、酸が食道やのどに上がってくるのを防ぎ、喉頭炎を悪化させるのどの炎症や炎症などの症状を緩和します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界閉塞性喉頭炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の閉塞性喉頭炎治療市場：成長率分析
• 世界の閉塞性喉頭炎治療市場の実績：規模と成長, 2019-2024
• 世界の閉塞性喉頭炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界閉塞性喉頭炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の閉塞性喉頭炎治療市場薬による、実績と予測, 2019-2024, 2024-2029F, 2034F
• グルココルチコイド
• デキサメタゾン
• エピネフリン
• 世界の閉塞性喉頭炎治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• その他の投与経路
• 世界の閉塞性喉頭炎治療市場医薬品流通経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の閉塞性喉頭炎治療市場グルココルチコイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒドロコルチゾン
• プレドニゾン
• メチルプレドニゾロン
• トリアムシノロン
• ベタメタゾン
• ブデソニド
• 世界の閉塞性喉頭炎治療市場デキサメタゾンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• デキサメタゾンリン酸ナトリウム
• デキサメタゾン経口液
• デキサメタゾン注射剤
• デキサメタゾン錠
• 世界の閉塞性喉頭炎治療市場エピネフリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• エピネフリン注射
• エピネフリン自己注射器
• エピネフリンネブライザー溶液
• エピネフリン吸入エアロゾル

第7章 地域別・国別分析

• 世界の閉塞性喉頭炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の閉塞性喉頭炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 閉塞性喉頭炎治療市場：競合情勢
• 閉塞性喉頭炎治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Reckitt Benckiser Group plc
• Teva Pharmaceutical Industries Limited
• Sun Pharmaceutical Industries Limited
• Macleods Pharmaceuticals Limited
• Aurobindo Pharma Limited
• Cipla Limited
• Cadila Healthcare Limited
• Dr. Reddy's Laboratories Limited
• Lupin Limited
• Glenmark Pharmaceuticals Limited
• Torrent Pharmaceuticals Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 閉塞性喉頭炎治療市場2029：新たな機会を提供する国
• 閉塞性喉頭炎治療市場2029：新たな機会を提供するセグメント
• 閉塞性喉頭炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Obstructive laryngitis treatment involves medical methods to manage inflammation and obstruction of the larynx (voice box), which affects breathing and vocal function. This treatment aims to relieve symptoms such as hoarseness, breathing difficulties, and throat discomfort, while also reducing inflammation and clearing the obstruction.

The primary medications used for obstructive laryngitis include glucocorticoids, dexamethasone, and epinephrine. Glucocorticoids, a type of steroid medication, help reduce inflammation and swelling in the throat for patients with obstructive laryngitis. These medications can be administered through various routes, including oral and intravenous, and are available through different distribution channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

The obstructive laryngitis treatment market research report is one of a series of new reports from The Business Research Company that provides obstructive laryngitis treatment market statistics, including obstructive laryngitis treatment industry global market size, regional shares, competitors with an obstructive laryngitis treatment market share, detailed obstructive laryngitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the obstructive laryngitis treatment industry. This obstructive laryngitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obstructive laryngitis treatment market size has grown strongly in recent years. It will grow from $1.95 $ billion in 2024 to $2.07 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rising incidence of conditions such as vocal cord paralysis, increased demand for effective treatment options, rise in respiratory and laryngeal disorders, growth in telemedicine, and rising awareness and use of voice therapy.

The obstructive laryngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.57 $ billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing the need for treatment options, growing incidences of bacterial and viral infections, growing aging population, rising exposure to harmful chemicals, and rising healthcare expenditure. Major trends in the forecast period include technological advancements, integration of telemedicine, biologic therapies, diagnostic imaging, and machine learning.

The growth of the obstructive laryngitis treatment market is expected to be driven by the rising incidence of bacterial and viral infections. These infections, caused by microorganisms such as bacteria and viruses, invade the body, reproduce, and disrupt normal bodily functions. Factors contributing to the increasing incidence of these infections include more global travel, climate change, and antibiotic resistance. Treatment for obstructive laryngitis typically involves antibiotics and corticosteroids to eliminate pathogens and reduce inflammation, while viral infections are managed with symptomatic treatments, corticosteroids for severe inflammation, and supportive care such as voice rest and hydration. For example, in November 2023, the World Health Organization (WHO) estimated that there would be around 10.6 million cases of tuberculosis (TB) globally in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. This rising incidence of bacterial and viral infections is fueling growth in the obstructive laryngitis treatment market.

Leading companies in the obstructive laryngitis treatment market are concentrating on developing innovative solutions, such as chewable tablets, to prevent acid from escaping into the esophagus, thereby relieving pain and discomfort. A chewable tablet is a solid form of medication designed to be chewed before swallowing, promoting easier ingestion and quicker absorption. For example, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based manufacturing company, launched a chewable anti-reflux antacid tablet containing sodium alginate and potassium bicarbonate. This chewable tablet is primarily used to treat acid reflux and gastroesophageal reflux disease (GERD). In the context of laryngitis treatment, it helps reduce irritation in the larynx caused by acid reflux, which can contribute to or worsen laryngitis. By forming a protective barrier in the stomach, the tablet prevents acid from rising into the esophagus and throat, easing symptoms such as throat irritation and inflammation that can worsen laryngitis.

In February 2024, GSK plc, a UK-based pharmaceutical and biotechnology company that develops and manufactures vaccines and specialty medicines to prevent and treat disease, acquired Aiolos Bio, Inc. for an undisclosed amount. The acquisition enhances GSK's respiratory portfolio by integrating AIO-001, a long-acting anti-lymphopoietin monoclonal antibody that targets unmet needs in asthma treatment, particularly for patients with low T2 inflammation where current options are limited. Aiolos Bio, Inc. is a UK-based biotechnology company that focuses on developing treatments for respiratory and inflammatory conditions.

Major companies operating in the obstructive laryngitis treatment market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Macleods Pharmaceuticals Limited, Aurobindo Pharma Limited, Cipla Limited, Cadila Healthcare Limited, Dr. Reddy's Laboratories Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Mankind Pharma Limited, Unichem Laboratories Limited, Mylan N.V., Strides Pharma Science Limited, USV Private Limited

North America was the largest region in the obstructive laryngitis treatment market in 2023. The regions covered in the obstructive laryngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the obstructive laryngitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obstructive laryngitis treatment market includes revenues earned by entities by providing services such as pharmacological treatments, voice therapy, medical monitoring and diagnostics, and surgical interventions and related corticosteroid medications, antibiotics, antihistamines, and nasal sprays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obstructive Laryngitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on obstructive laryngitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obstructive laryngitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obstructive laryngitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Medication: Glucocorticoid; Dexamethasone; Epinephrine
• 2) By Route Of Administration: Oral; Intravenous; Other Route Of Administration
• 3) By Drug Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• Subsegments:
• 1) By Glucocorticoid: Hydrocortisone; Prednisone; Methylprednisolone; Triamcinolone; Betamethasone; Budesonide;
• 2) By Dexamethasone: Dexamethasone Sodium Phosphate; Dexamethasone Oral Solution; Dexamethasone Injectable; Dexamethasone Tablets;
• 3) By Epinephrine: Epinephrine Injection; Epinephrine Autoinjectors; Epinephrine Nebulizer Solution; Epinephrine Inhalation Aerosol
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Obstructive Laryngitis Treatment Market Characteristics

3. Obstructive Laryngitis Treatment Market Trends And Strategies

4. Obstructive Laryngitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Obstructive Laryngitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Obstructive Laryngitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Obstructive Laryngitis Treatment Market Growth Rate Analysis
• 5.4. Global Obstructive Laryngitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Obstructive Laryngitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Obstructive Laryngitis Treatment Total Addressable Market (TAM)

6. Obstructive Laryngitis Treatment Market Segmentation

• 6.1. Global Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucocorticoid
• Dexamethasone
• Epinephrine
• 6.2. Global Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Other Route Of Administration
• 6.3. Global Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.4. Global Obstructive Laryngitis Treatment Market, Sub-Segmentation Of Glucocorticoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrocortisone
• Prednisone
• Methylprednisolone
• Triamcinolone
• Betamethasone
• Budesonide
• 6.5. Global Obstructive Laryngitis Treatment Market, Sub-Segmentation Of Dexamethasone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dexamethasone Sodium Phosphate
• Dexamethasone Oral Solution
• Dexamethasone Injectable
• Dexamethasone Tablets
• 6.6. Global Obstructive Laryngitis Treatment Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epinephrine Injection
• Epinephrine Autoinjectors
• Epinephrine Nebulizer Solution
• Epinephrine Inhalation Aerosol

7. Obstructive Laryngitis Treatment Market Regional And Country Analysis

• 7.1. Global Obstructive Laryngitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Obstructive Laryngitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Obstructive Laryngitis Treatment Market

• 8.1. Asia-Pacific Obstructive Laryngitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Obstructive Laryngitis Treatment Market

• 9.1. China Obstructive Laryngitis Treatment Market Overview
• 9.2. China Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Obstructive Laryngitis Treatment Market

• 10.1. India Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Obstructive Laryngitis Treatment Market

• 11.1. Japan Obstructive Laryngitis Treatment Market Overview
• 11.2. Japan Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Obstructive Laryngitis Treatment Market

• 12.1. Australia Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Obstructive Laryngitis Treatment Market

• 13.1. Indonesia Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Obstructive Laryngitis Treatment Market

• 14.1. South Korea Obstructive Laryngitis Treatment Market Overview
• 14.2. South Korea Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Obstructive Laryngitis Treatment Market

• 15.1. Western Europe Obstructive Laryngitis Treatment Market Overview
• 15.2. Western Europe Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Obstructive Laryngitis Treatment Market

• 16.1. UK Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Obstructive Laryngitis Treatment Market

• 17.1. Germany Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Obstructive Laryngitis Treatment Market

• 18.1. France Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Obstructive Laryngitis Treatment Market

• 19.1. Italy Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Obstructive Laryngitis Treatment Market

• 20.1. Spain Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Obstructive Laryngitis Treatment Market

• 21.1. Eastern Europe Obstructive Laryngitis Treatment Market Overview
• 21.2. Eastern Europe Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Obstructive Laryngitis Treatment Market

• 22.1. Russia Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Obstructive Laryngitis Treatment Market

• 23.1. North America Obstructive Laryngitis Treatment Market Overview
• 23.2. North America Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Obstructive Laryngitis Treatment Market

• 24.1. USA Obstructive Laryngitis Treatment Market Overview
• 24.2. USA Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Obstructive Laryngitis Treatment Market

• 25.1. Canada Obstructive Laryngitis Treatment Market Overview
• 25.2. Canada Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Obstructive Laryngitis Treatment Market

• 26.1. South America Obstructive Laryngitis Treatment Market Overview
• 26.2. South America Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Obstructive Laryngitis Treatment Market

• 27.1. Brazil Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Obstructive Laryngitis Treatment Market

• 28.1. Middle East Obstructive Laryngitis Treatment Market Overview
• 28.2. Middle East Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Obstructive Laryngitis Treatment Market

• 29.1. Africa Obstructive Laryngitis Treatment Market Overview
• 29.2. Africa Obstructive Laryngitis Treatment Market, Segmentation By Medication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Obstructive Laryngitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Obstructive Laryngitis Treatment Market, Segmentation By Drug Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Obstructive Laryngitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Obstructive Laryngitis Treatment Market Competitive Landscape
• 30.2. Obstructive Laryngitis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Obstructive Laryngitis Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline plc
• 31.3. Eli Lilly and Company
• 31.4. Boehringer Ingelheim International GmbH
• 31.5. Reckitt Benckiser Group plc
• 31.6. Teva Pharmaceutical Industries Limited
• 31.7. Sun Pharmaceutical Industries Limited
• 31.8. Macleods Pharmaceuticals Limited
• 31.9. Aurobindo Pharma Limited
• 31.10. Cipla Limited
• 31.11. Cadila Healthcare Limited
• 31.12. Dr. Reddy's Laboratories Limited
• 31.13. Lupin Limited
• 31.14. Glenmark Pharmaceuticals Limited
• 31.15. Torrent Pharmaceuticals Limited

32. Global Obstructive Laryngitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Obstructive Laryngitis Treatment Market

34. Recent Developments In The Obstructive Laryngitis Treatment Market

35. Obstructive Laryngitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Obstructive Laryngitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Obstructive Laryngitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Obstructive Laryngitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer